Haemonetics Corporation: net_income
| Value | {"amount": 97308, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-03-30 – 2026-03-28 |
| Status | current |
| Entity | Haemonetics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9aa97bef-6e35-4c10-87f3-f4686efdf7ee
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000313143-26-000074Retrieved: 2026-08-19T07:27:23.650330+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000313143/net-income/2026-03-28 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9aa97bef-6e35-4c10-87f3-f4686efdf7ee
History
- supersedes {"amount": 97308000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0000313143-26-000050)